Products billed under this code include Esperoct.
The billing unit for this code changed over time, so payment limits from different quarters may not be directly comparable. Check the billing unit column below.
Payment limit per 1 IU, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Esperoct | Novo Nordisk, Inc | 00169-8100-01 | 1 | $2.363 |
| Esperoct | Novo Nordisk, Inc | 00169-8150-01 | 1 | $2.363 |
| Esperoct | Novo Nordisk, Inc | 00169-8200-01 | 1 | $2.363 |
| Esperoct | Novo Nordisk, Inc | 00169-8300-01 | 1 | $2.363 |
| Esperoct | Novo Nordisk, Inc | 00169-8400-01 | 1 | $2.363 |
| Esperoct | Novo Nordisk, Inc | 00169-8500-01 | 1 | $2.363 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $2.363 | +$0.067 | 1 IU | Inj recombin esperoct per iu | v1, posted September 17, 2026 |
| 3Q26 | $2.296 | +$0.071 | 1 IU | Inj recombin esperoct per iu | v1, posted September 15, 2026 |
| 2Q26 | $2.225 | −$0.013 | 1 IU | Inj recombin esperoct per iu | v1, posted September 15, 2026 |
| 1Q26 | $2.238 | +$0.015 | 1 IU | Inj recombin esperoct per iu | v1, posted September 15, 2026 |
| 4Q25 | $2.223 | −$0.038 | 1 IU | Inj recombin esperoct per iu | v1, posted September 8, 2026 |
| 3Q25 | $2.261 | +$0.123 | 1 IU | Inj recombin esperoct per iu | v1, posted March 10, 2026 |
| 2Q25 | $2.138 | −$0.047 | 1 IU | Inj recombin esperoct per iu | v1, posted March 10, 2026 |
| 1Q25 | $2.185 | +$0.017 | 1 IU | Inj recombin esperoct per iu | v1, posted December 19, 2025 |
| 4Q24 | $2.168 | $0.00 | 1 IU | Inj recombin esperoct per iu | v1, posted June 11, 2025 |
| 3Q24 | $2.168 | +$0.057 | 1 IU | Inj recombin esperoct per iu | v1, posted June 11, 2025 |
| 2Q24 | $2.111 | +$0.035 | 1 IU | Inj recombin esperoct per iu | v1, posted March 11, 2025 |
| 1Q24 | $2.076 | +$0.021 | 1 IU | Inj recombin esperoct per iu | v1, posted December 19, 2024 |
| 4Q23 | $2.055 | −$0.053 | 1 IU | Inj recombin esperoct per iu | v1, posted October 10, 2024 |
| 3Q23 | $2.108 | +$0.043 | 1 IU | Inj recombin esperoct per iu | v1, posted June 5, 2024 |
| 2Q23 | $2.065 | +$0.023 | 1 IU | Inj recombin esperoct per iu | v1, posted February 23, 2024 |
| 1Q23 | $2.042 | −$0.062 | 1 IU | Inj recombin esperoct per iu | v1, posted December 6, 2023 |
| 4Q22 | $2.104 | +$0.002 | 1 IU | Inj recombin esperoct per iu | v1, posted June 22, 2023 |
| 3Q22 | $2.102 | +$0.034 | 1 IU | Inj recombin esperoct per iu | v1, posted June 9, 2023 |
| 2Q22 | $2.068 | −$0.115 | 1 IU | Inj recombin esperoct per iu | v1, posted December 14, 2022 |
| 1Q22 | $2.183 | −$0.044 | 1 IU | Inj recombin esperoct per iu | v1, posted June 8, 2022 |
| 4Q21 | $2.227 | – | 1 IU | Inj recombin esperoct per iu | v1, posted June 2, 2022 |
| 3Q21 | $2.217 | −$0.022 | 1 i.u. | Inj recombin esperoct per iu | v1, posted June 2, 2022 |
| 2Q21 | $2.239 | −$0.009 | 1 i.u. | Inj recombin esperoct per iu | v1, posted March 1, 2022 |
| 1Q21 | $2.248 | – | 1 i.u. | Inj recombin esperoct per iu | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
